Supporting women's health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial.

Autor: Singleton AC; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. anna.singleton@sydney.edu.au., Raeside R; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Partridge SR; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Prevention Research Collaboration, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Hyun KK; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Cardiology, Concord Repatriation General Hospital, Sydney, NSW, Australia., Tat-Ko J; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Sum SCM; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Hayes M; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Chow CK; Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.; George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.; Research Education Network, Western Sydney Local Health District, Sydney, NSW, Australia., Thiagalingam A; Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.; George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia., Maka K; Department of Physiotherapy, Westmead Hospital, Sydney, NSW, Australia.; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, NSW, Australia., Sherman KA; Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia., Elder E; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, NSW, Australia., Redfern J; Engagement and Co-design Research Hub, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.; Research Education Network, Western Sydney Local Health District, Sydney, NSW, Australia.
Jazyk: angličtina
Zdroj: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Dec; Vol. 17 (6), pp. 1533-1545. Date of Electronic Publication: 2022 Apr 23.
DOI: 10.1007/s11764-022-01209-9
Abstrakt: Purpose: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors' self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health.
Methods: Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat).
Setting: public Breast Cancer Institute (Sydney, Australia).
Eligibility Criteria: adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent.
Primary Outcome: Self-Efficacy for Managing Chronic Disease Scale at 6 months. Process data: message delivery analytics, cost, and post-intervention survey.
Results: Participants (N = 160; mean age ± SD 55.1 ± 11.1 years) were recruited 29th-March-2019 to 7th-May-2020 and randomised (n = 80 EMPOWER-SMS: n = 80 control). Baseline mean self-efficacy was high (I: 7.1 [95%CI 6.6, 7.5], C: 7.4 [7, 7.8]). Six-month follow-up: no significant differences between groups for self-efficacy (I: 7.6 [7.3, 7.9], C: 7.6 [7.3, 7.9], adjusted mean difference 0 (95%CI 0.4, 0.4), QOL, mental health, physical activity, or BMI. Significantly less EMPOWER-SMS participants missed ≥ 1 endocrine therapy medication doses compared to control (I: 3/42[7.1%], C: 8/47[17.0%], Adjusted RR 0.13 [95%CI 0.02, 0.91]). Text messages were delivered successfully (7925/8061, 98.3%), costing $13.62USD/participant. Participants strongly/agreed EMPOWER-SMS was easy-to-understand (64/64; 100%), useful (58/64; 90.6%), motivating for lifestyle change (43/64; 67.2%) and medication adherence (22/46; 47.8%).
Conclusion: EMPOWER-SMS was feasible, inexpensive, acceptable for delivering health information to breast cancer survivors between medical appointments, with minor improvements in medication adherence.
Implications for Cancer Survivors: Text messages offer a feasible strategy for continuity-of-care between medical appointments.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: